
Sign up to save your podcasts
Or


Join us for part 2 of BrainStorm’s interview with Dr. Suzanne LeBlang, Director of Clinical Relations at Focused Ultrasound Foundation (www.fusfoundation.org). Host Meryl Comer and Dr. LeBlang discuss eligibility criteria and applications for the ground-breaking technology of focused ultrasound – a non-invasive procedure for treating tremors in Parkinson’s disease and those newly diagnosed with Alzheimer’s disease. This technological advancement can target and treat tissue deep within the brain, enhance drug delivery, and facilitate the removal of amyloid plaques. As featured on CBS 60 Minutes, patients are awake during this transformational procedure. You won’t want to miss part 2 of this interview!
Produced by Susan Quirk and Amber Roniger
Support the show
By Meryl Comer, UsAgainstAlzheimer's4.7
1414 ratings
Join us for part 2 of BrainStorm’s interview with Dr. Suzanne LeBlang, Director of Clinical Relations at Focused Ultrasound Foundation (www.fusfoundation.org). Host Meryl Comer and Dr. LeBlang discuss eligibility criteria and applications for the ground-breaking technology of focused ultrasound – a non-invasive procedure for treating tremors in Parkinson’s disease and those newly diagnosed with Alzheimer’s disease. This technological advancement can target and treat tissue deep within the brain, enhance drug delivery, and facilitate the removal of amyloid plaques. As featured on CBS 60 Minutes, patients are awake during this transformational procedure. You won’t want to miss part 2 of this interview!
Produced by Susan Quirk and Amber Roniger
Support the show

43,704 Listeners

11,909 Listeners

112,601 Listeners

56,441 Listeners

3,388 Listeners

3,525 Listeners

9,233 Listeners

162 Listeners

8,957 Listeners

5,455 Listeners

8,179 Listeners

10,886 Listeners

2,144 Listeners

5,761 Listeners

606 Listeners